In agreement with the initial isolation of human SPARCL1 (hSPARCL1) from high endothelial venules, subsequent publications showed that hSPARCL1 expression in different tumors, including colorectal carcinoma (CRC), is highly associated with blood vessel endothelial cells [1, 4]. Here, SPARCL1 is linked to colorectal carcinoma.